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Human genetics is the study of inheritance as it occurs in human beings. 
It encompasses several overlapping areas, including cytogenetics, 
molecular genetics, biochemical genetics, genomics, clinical genetics, 
developmental genetics, population genetics and genetic counselling. 
Genes can be the common factor underlying the qualities of most 
human-inherited traits. The study of human genetics can be useful, 
as it can answer questions about human nature, understand diseases 
and development of effective disease treatment, and contribute to 
understanding genetics of human life. DNA contains instructions 
for everything our cells do, from conception until death. Studying 
the human genome allows us to explore fundamental details about 
ourselves.[1]
Genomics refers to the field of genetics focused on structural 
and functional studies of the genome. A genome is all the DNA 
contained within an organism or a cell, including nuclear and 
mitochondrial DNA. The human genome is the total collection of 
all genes in a human being contained in the human chromosomes 
and composed of >3 billion nucleotides. In April 2003, in arguably 
the biggest scientific advance of the last 2 decades, the Human 
Genome Project (HGP) was able to sequence all the DNA in the 
human genome, and to discover that the human genome was 
composed of ~20 000 protein-coding genes.
 Human reproduction shows inheritance patterns, both of the 
type discovered by Mendel (autosomal inheritance) and of sex-
linked inheritance. As we are dealing with people rather than 
experimental organisms that can be studied in the laboratory, 
human geneticists must resort to scrutinising records in the hope 
that information about inheritance has shown itself in the pedigree 
analysis of the phenotype of parents and their children. As is 
often the case, nature provides the best laboratory. A member of a 
family who first comes to the attention of a geneticist is called the 
proband. Usually, the phenotype of the proband is exceptional in 
some way (e.g. characteristic facies or short stature). The geneticist 
is then able to trace the history of the phenotype in the proband 
back through the history of the family and draws a family tree or 
pedigree. In the study of genetic disorders, four general patterns 
of inheritance are distinguishable by pedigree analysis: autosomal 
recessive, autosomal dominant, X-linked recessive, and X-linked 
dominant.
A glossary of terms is set out in Table 1.
The Human Genome Project
The HGP, the international quest to understand the genomes of 
humans and other organisms, was planned to provide information 
on a wide range of basic questions: how many genes we have, how 
cells work, how living organisms evolved, how single cells develop 
into complex creatures, and what exactly happens when we become 
unwell. Importantly, it was hoped that the HGP would not merely 
answer questions regarding our molecular composition, but also 
usher in a new era of molecular medicine, with precise novel 
approaches to prevent, diagnose and treat human disease.[2] 
The HGP began in the USA in 1990, when the National 
Institutes of Health and the US Department of Energy joined 
forces with international partners to decipher the massive amount 
of information contained in our genomes. The HGP began with a 
set of ambitious goals, but has exceeded nearly all its targets. HGP 
scientists have produced an increasingly detailed series of maps that 
help geneticists navigate through human DNA and have mapped 
and sequenced the genomes of important experimental organisms. 
The HGP began transforming biology as soon as it started, because 
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Table 1. A glossary of terms
Chromosomes Thread-like structure of nucleic acids and proteins found in the nucleus of most living cells, carrying genetic information 
in the form of genes
DNA Deoxyribonucleic acid is a long molecule made of two twisting, paired strands. Each strand is made of four chemical units, 
called nucleotide bases, strung together in a precise order, just as letters string together to make specific words. The bases are 
adenine (A), guanine (G), cytosine (C) and thymine (T). The bases on opposite strands pair specifically; an A always pairs 
with a T, and a C always with a G. Each such pair is called a base pair of DNA 
Gene Functional unit of DNA. Each of the human chromosomes contains hundreds to thousands of genes 
Genome All the DNA contained within an organism or a cell, including nuclear and mitochondrial DNA
Genomics The field of genetics concerned with structural and functional studies of the genome
Human genetics The study of inheritance as it occurs in human beings
Mutation Changes in DNA spelling that can prevent proteins from functioning normally and cause health problems 
Protein Proteins comprise essential parts of tissues and guide chemical reactions in living things. They are made of 20 different 
building blocks called amino acids. The DNA sequence of a gene determines the amino acid sequence of the protein that 
gene encodes. The amino acid sequence of the protein is, in turn, responsible for the protein’s shape and function 
RNA Ribonucleic acid is chemically similar to DNA, except that it is single stranded, not double stranded; it contains the base 
uracil (U) instead of thymine (T); it can migrate out of the nucleus. The sequences of most RNA molecules are translated 
to make proteins
SNP Single-nucleotide polymorphisms or one-letter variations in the DNA sequence. SNPs contribute to differences among 
individuals. The majority have no effect, others cause subtle differences in countless characteristics, such as appearance, 
while some affect the risk for certain diseases 
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the information it generated was disseminated rapidly through 
unrestricted, public databases and has fuelled the unmatched pace 
of discovery into the genetic basis of many human conditions. 
The genetic basis of health and 
disease
Genes are made up of DNA, which encodes all genetic information. 
Almost all human cells contain 23 pairs of chromosomes; each 
chromosome contains a molecule of DNA with hundreds to thousands 
of genes arrayed along it. Genes usually code for proteins, the diverse 
molecules that perform a wide variety of specialised tasks in the 
cells.[2] Alterations in our genes are responsible for >5 000 clearly 
hereditary diseases, such as hypertrophic cardiomyopathy, sickle cell 
disease, cystic fibrosis and Huntington disease, to name a few. The 
altered sequence of many other genes influences the development of 
common illnesses that arise through the interaction of genes with the 
environment. 
Linking a gene with a specific disease was historically a slow, 
imprecise and painstaking process before the advent of the HGP and 
molecular genomics. In 1989, only 4 genes were definitively linked 
with disease through analysis of heredity. Ten years later, the list 
included >100 genes. Consider two gene hunts, 8 years apart: in 1989, 
scientists found the gene for cystic fibrosis after a 9-year search; 
8 years later, a gene for Parkinson disease was mapped in only 9 days, 
and precisely described within 9 months.
Almost all the 100 trillion cells in the human body contain a 
copy of the entire human genome, the complete set of genetic 
instructions necessary to build a human being, finely tuned by 
various epigenetic mechanisms to control our biology. Knowing 
the DNA sequence of a gene reveals the basic structure of the 
protein that gene encodes. Scientists can sometimes deduce the 
3-dimensional shape and function of the protein as well. Often, they 
can classify the protein because of similarities to other proteins. 
The role of human genetics in medicine
Examining how a gene is mutated in an individual has multiple 
utility:[2]
Diagnosis. Genetic analysis can now classify conditions such as 
colon cancer, skin cancer and lung cancer into finer categories, which 
is important because improved genotypic classification allows more 
precise and efficacious therapies. Detailed molecular classification 
is also emerging in cardiovascular disease, mental health and other 
areas where genetic underpinning of human health is becoming 
better understood. 
Pharmacogenomics. The practice of tailoring drugs for patients, 
whose individual response can be predicted by genetic finger-
printing, is fast gaining traction. For example, in cancer patients 
facing chemotherapy, not only can this field allow for prediction 
of an individual’s metabolic responses to drugs that can minimise 
side-effects and maximise efficacy, but genetic fingerprinting of their 
tumour can inform which chemotherapy choices are most likely to 
be effective. Better understanding of genetics promises a future of 
precise, customised medical treatments, i.e. precision medicine.
Prognosis. More accurate diagnosis allows more precise prediction 
about the natural history and course of a disease. For instance, the 
genetic work-up in a patient with familial hypercholesterolaemia or 
prostate cancer can inform us of the likely risk of adverse outcomes 
in those individuals. Molecular genetic screening also allows patients 
and doctors to weigh the risks and benefits of different treatments. 
Prevention. Once scientists figure out which DNA sequence 
changes in a gene can cause disease, healthy people can be tested to 
see whether they risk developing specific conditions and appropriate 
preventive strategies can be employed early. For example, in many 
countries babies are routinely screened for phenylketonuria, a 
metabolic disorder that prevents the breakdown of phenylalanine, 
which is toxic to the nervous system. In the past, children with the 
condition became severely intellectually disabled but the screening 
programme identifies children with the enzyme deficiency, allowing 
them to grow normally on a diet that strictly avoids phenylalanine. 
Molecular approaches to both newborn screening and adult risk 
stratification are rapidly being refined and applied. 
Carrier screening. There are some genetic conditions where 
people who have mutated genes will not be ill themselves, but they 
can pass the disease to their offspring. For instance, carrier testing 
for sickle cell disease, which is a major cause of morbidity and 
mortality in Africa, has been available and widely used for years. 
Gene-based therapy. Replacing a misspelled gene with a 
functional gene has long been an appealing idea but has remained 
challenging to implement. Small groups of patients have undergone 
gene-replacement therapy in clinical trials for more than 2 decades, 
but this remains largely an experimental treatment. Recently, 
gene-based therapies have been shown to be efficacious in many 
conditions such as adenine deaminase deficiency, Duchenne 
muscular dystrophy, sickle cell anaemia and HIV. For years, effort 
has been put into designing drugs based on an understanding 
of how genes work and what exactly happens at the molecular 
level to cause disease. For example, it is possible to administer a 
small molecule that interacts with the protein – as many drugs 
do – and change its behaviour. Protein kinase inhibitors, used for 
the management of chronic myelogenous leukaemia, were one of 
the first examples of such gene-based therapy, using a rationally 
designed drug target based on the understanding of the molecular 
pathways resulting from a fusion protein caused by a translocation 
of chromosomes 9 and 22. 
In this issue of CME, Krause[3] provides an update on novel genetic 
testing platforms, and reviews their advantages and limitations. 
Fieggen et al.[4] discuss a pragmatic approach to the genetic diag-
nosis of developmental delay and tools that are appropriate and 
cost-effective in South African settings. Finally, Scott et al.[5] suggest 
a genetic approach to the understanding and diagnosis of suspected 
hereditary breast and colorectal cancer.
It is our hope that the readers will find 
this issue to be interesting and instructive. 
Karen J Fieggen
Division of Human Genetics,  
Department of Medicine, Faculty of  
Health Sciences, Groote Schuur  
Hospital and University of Cape Town,  
South Africa
Ntobeko A B Ntusi
Division of Cardiology, Department of 
Medicine, Faculty of Health Sciences, 
University of Cape Town and Groote 
Schuur Hospital; Cape Universities 
Body Imaging Centre, Faculty of Health 
Sciences, University of Cape Town; and 
Hatter Institute for Cardiovascular 
Research in Africa, Department of 
Medicine, Faculty of Health Sciences, 
University of Cape Town, South Africa
ntobeko.ntusi@uct.ac.za
206       April 2019, Vol. 109, No. 4
CME
1. Kork BR. Introduction to human genetics. In: Robertson D, Williams GH, eds. Clinical and 
Translational Science. Principles of Human Research. 2nd ed. London, UK: Elsevier, 2017:281-311.
2. Genetics: The future of medicine. The Human Genome Project – exploring our molecular selves. 
https://www.genome.gov/pages/educationkit/images/nhgri/pdf (accessed 8 March 2019).
3. Krause A. New genetic technologies: Advantages and limitations. S Afr Med J 2019;109(4):207-209. 
https://doi.org/10.7196/SAMJ.2019.v109i4.13990
4. Fieggen KJ, Lambie LA, Donald KA. Investigating developmental delay in South Africa: A pragmatic 
approach. S Afr Med J 2019;109(4):210-213. https://doi.org/10.7196/SAMJ.2019.v109i4.13991 
5. Scott CJ, Schoeman M, Urban MF. Cancer genetics: An approach to suspected hereditary breast 
and colorectal cancer. S Afr Med J 2019;109(4):214-218. https://doi.org/10.7196/SAMJ.2019.
v109i4. 13992
S Afr Med J 2019;109(4):204-206. DOI:10.7196/SAMJ.2019.v109i4.14037
